Related Experiment Video

Updated: Jul 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Severe community acquired pneumonia due to Staphylococcus aureus in children. About two cases]

Abir Bedoui1, Mounira Braham, Bahri Mahjoub

  • 1Service De Pediatrie, CHU Tahar Sjar, Mahdia, Tunisie.

La Tunisie Medicale
|December 30, 2006
PubMed

Insights

Severe staphylococcal pneumonia, typically affecting infants, was observed in two young children without immune deficiencies. Identifying toxin-producing strains like Panton and Valentine leukocidin is key to understanding this rare condition.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacterial Pneumonia Pathogenesis
  • Microbial Toxinology

Background:

  • Staphylococcal pneumonia is predominantly an infant illness, with rare occurrences in older children.
  • Severe bacterial pneumonia necessitates understanding atypical presentations and causative agents.
  • Immunocompromised status is a common risk factor for severe pediatric infections.

Observation:

  • Two children, aged 6 years and 3.5 years, presented with severe staphylococcal pneumonia.
  • These cases occurred in the absence of any known immunodepressive conditions.
  • The clinical presentation was considered a particular and severe form of the illness.

Findings:

  • The causative Staphylococcus strains produced Panton and Valentine leukocidin (PVL).
  • PVL-producing strains are associated with severe necrotizing pneumonia.
  • This finding aids in comprehending the pathophysiology of atypical staphylococcal pneumonia.

Implications:

  • Highlights the potential for severe staphylococcal pneumonia in immunocompetent children.
  • Emphasizes the role of specific bacterial toxins in disease severity.
  • Suggests the need for vigilant diagnosis and management of staphylococcal pneumonia in pediatric populations.

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.